Correlation of Serum Immunoglobulin-E Level With Allergic Rhinitis Severity Based on Symptoms Classification
DOI:
https://doi.org/10.26911/theijmed.2026.11.2.946Abstract
Background: Allergic rhinitis (AR) is defined as an Imunoglobulin-E (IgE) -mediated reactions to inhaled allergens in atopic individual, with symptoms including runny nose, itchy nose, nasal congestion, and sneezing. Serum IgE was a reliable diagnostic marker for allergic rhinitis. This study aimed to reveal the correlation between IgE levels and the severity of allergic rhinitis symptoms according to the Allergic Rhinitis and Its Impacts on Asthma (ARIA) classification.
Subject and Methods: A cross-sectional observational study was conducted involving 45 patients diagnosed with allergic rhinitis at the Otorhinolaryngology outpatient clinic. Subjects were identified through clinical evaluation, blood screening, and skin prick tests. Serum total IgE levels were measured using the enzyme-linked immunosorbent assay (ELISA) method. Allergic rhinitis severity was categorized according to the ARIA classification into mild and moderate groups. Data were analyzed using the Chi-square test, and the association was presented as prevalence ratio (PR) with a 95% confidence interval (CI).
Results: Forty-five patients with allergic rhinitis comprised of 30 females (66.70%) and 15 males (33.30%). The average IgE levels examination results were 204.24 IU/ml, with 23 subjects (48.89%) classified as standard, while those with higher-than-normal IgE levels were 22 subjects (53.49%). The Pearson chi-square test showed a significant correlation between higher-than-normal IgE levels and ARIA severity (PR = 1.65; 95% CI = 1.03–2.64; p = 0.045)
Conclusion: Elevated serum IgE levels were significantly associated with greater allergic rhinitis severity based on ARIA classification and may serve as a useful supporting marker for disease severity assessment.
References
An SY, Choi HG, Kim SW, Park B, Lee JS, Jang JH, et al. (2015). Analysis of various risk factors predisposing subjects to allergic rhinitis. Asian Pac J Allergy Immunol. doi:10.12932/-AP0554.33.2.2015.
Ayanoğlu M, Can D, Nacaroğlu HT, Günay İ, Kamalı H, Karkiner C, et al. (2021). Prevalence of allergic rhinitis and risk factors in school children. Trends Pediatr. 2(2): 67–77. doi:10.5222/TP.2021.21939.
Bagus IG, Widiatmaja P, Raharjo SS, Widyaningsih P (2024). Effective-ness of acupuncture on the quality of life in allergic rhinitis patients: meta-analysis. 9: 105–117. doi: 10.26911/theijmed.2024.9.1.719
Bousquet J, Hellings PW, Agache I, Bedbrook A, Bachert C, Bergmann KC, et al. (2016). ARIA 2016: care pathways implementing emerging technologies for predictive medicine in rhinitis and asthma across the life cycle. Clin Transl Allergy. 6: 47. doi:10.1186/s13601-016-0137-4.
Chong SN, Chew FT (2018). Epidemiology of allergic rhinitis and associated risk factors in Asia. World Allergy Organ J. 11(1). doi:10.1186/s40413-018-0198-z.
Ciprandi G, Comite P, Ferrero F, Fontana V, Bruzzone M, Mussap M (2016). Serum allergen-specific IgE, allergic rhinitis severity, and age. Rhinology. 54(3): 231–238. doi:10.4193/Rhin15.276.
Corsico AG, De Amici M, Ronzoni V, Giunta V, Mennitti MC, Viscardi A, et al. (2017). Allergen-specific immunoglobulin E and allergic rhinitis severity. Allergy Rhinol. 8(1). doi:10.2500/ar.2017.8.0199.
Deb A, Mukherjee S, Kumar Saha B, Sharma Sarkar B, Pal J, Pandey N, et al. (2014). Profile of patients with allergic rhinitis: a clinic-based cross-sectional study from Kolkata, India. J Clin Diagn Res. 8(1): 67–70. doi:10.7860/JCDR/2014/7334.3952
Fröhlich M, Pinart M, Keller T, Reich A, Cabieses B, Hohmann C, et al. (2017). Is there a sex-shift in prevalence of allergic rhinitis and comorbid asthma from childhood to adulthood? A meta-analysis. Clin Transl Allergy. 7(1): 1–9. doi:10.-1186/s13601-017-0176-5.
Fujioka K, Kasahara A, Kida T, Fujii W, Seno T, Wada M, et al. (2022). Effectiveness and safety of allergen immunotherapy in patients with allergic rhinitis complicated by rheumatic autoimmune diseases: a case series study. Allergy Asthma Clin Immunol. 18(1). doi:10.1186/-s13223-022-00678-5.
Kim YS, Kim HY, Ahn HS, Sohn TS, Song JY, Lee YB, et al. (2017). The association between tobacco smoke and serum immunoglobulin E levels in Korean adults. Intern Med. 56(19): 2571–2577. doi:10.2169/-internalmedicine.8502-16.
Klimek L, Bachert C, Pfaar O, Becker S, Bieber T, Brehler R, et al. (2019). ARIA guideline 2019: treatment of allergic rhinitis in the German health system. Allergol Select. 3(1): 22–50. doi:10.5414/ALX02120E.
Kwon SR, Park D, Shim SJ, Heo JY, Kwon SM, Seo DY (2016). The association between passive smoking and serum total immunoglobulin E and allergic diseases in Korean nonsmoking adults. Korean J Fam Pract. 6(6): 688–694. doi: 10.21215/kjfp.2016.6.6.688
Paula Couto TAP, et al. (2014). Total IgE plasma levels vary according to gender and age in Brazilian patients with allergic rhinitis. Clinics (Sao Paulo). 69(11): 740–744. doi:10.-6061/clinics/2014(11)07.
Platts-Mills TAE, Schuyler AJ, Erwin EA, Commins SP, Woodfolk JA (2016). IgE in the diagnosis and treatment of allergic disease. J Allergy Clin Immunol. 137(6): 1662–1670. doi:10.1016/j.jaci.2016.03.023.
Rengganis I, Rambe DS, Rumende CM, Abdullah M (2018). Total serum IgE levels among adult patients with intermittent and persistent allergic asthma. Med J Indones. 27(4): 279–283. doi:10.13181/mji.v27i4.2910.
Rosário CS, Murrieta-Aguttes M, Rosario NA (2021). Allergic rhinitis: impact on quality of life of adolescents. Eur Ann Allergy Clin Immunol. 53(6): 247–251. doi:10.23822/EURAN-NACI.1764-1489.176.
Samitas K, Carter A, Kariyawasam HH, Xanthou G (2018). Upper and lower airway remodelling mechanisms in asthma, allergic rhinitis and chronic rhinosinusitis: the one airway concept revisited. Allergy. 73: 993–1002. doi:10.1111/all.13324.
Shokouhi Shoormasti R, Fazlollahi MR, Kazemnejad A, Tayebi B, Nadali F, Sharif Shoushtari M, et al. (2018). IgE sensitization to inhalant allergens and its association with allergic diseases in adults. Iran J Allergy Asthma Immunol. 17(2): 123–133. https://pubmed.-ncbi.nlm.nih.gov/29757585/
Small P, Keith PK, Kim H (2018). Allergic rhinitis. Allergy Asthma Clin Immunol. 14(Suppl 2): 1–11. doi:10.1186/s13223-018-0280-7.
Srivastava T, Shamanna K, Viswanatha B (2018). Role of IgE and absolute eosinophil count as prognostic markers to determine the optimum duration of therapy in seasonal allergic rhinitis. Res Otolaryngol. 7(2): 36–42. doi:10.5923/j.otola-ryn.20180702.03.
Stemeseder T, Linglmayr E, Moser S, Lang R, Himly M, Oostingh GJ, et al. (2017). Influence of intrinsic and lifestyle factors on the development of IgE sensitization. Int Arch Allergy Immunol. 173(2): 99–104. doi:10.1159/000475499.
Sudiro M, Wiem Lestari B (2015). Prevalence of allergic rhinitis based on World Health Organization (ARIA-WHO) questionnaire among batch 2010 students of the Faculty of Medicine Universitas Padjadjaran. Althea Med J. doi:10.15850/amj.v2n4.658.
